The L-arginine-nitric oxide (NO) pathway plays a significant role in the physiopathology of chronic renal failure (CRF)1,2. Malnutrition, a common feature in CRF, adversely affects both uraemic patient morbidity and mortality3. L-arginine is a cationic amino acid, precursor for NO synthesis. We have previously demonstrated that the transport of L-arginine in platelets is increased in well-nourished CRF patients. In the present study, we have investigated in uraemic platelets, the correlation of NO synthesis, NO-synthase activity and L-arginine and nutritional status. A total of 17 uraemic patients on haemodialysis were included in the study. NO synthase (NOS) activity, cGMP and amino acid profiles in plasma were analyzed in malnourished and well-nourished patients. Basal NOS activity (pmol/108cells) in platelets, determined from the conversion of L-[3H]-arginine to L-[3H]-citrulline (pmol/108cells), was increased in well-nourished (0.38 ± 0.14) compared to malnourished patients (0.09 ± 0.02) and controls (0.17 ± 0.008). GMPc content (ELISA Kit, pmol/108cells) was also enhanced in platelets from well-nourished (0.64 ± 0.15) compared with controls (0.21 ± 0.09) and malnourished patients (0.18 ± 0.04). Plasma L-arginine concentration (μM) was significantly reduced in malnourished CRF patients (54 ± 14) and well-nourished CRF patients (86 ± 9) compared to controls (125 ± 5). Our results demonstrate that in malnourished uraemic patients, not only plasma L-arginine is reduced but their platelets lack the up-regulation of NO-synthase activity and NO synthesis present in well-nourished patients. A possible mechanism behind the reduction in the activity of the L-arginine-NO pathway in platelets from malnourished patients may be a diminished L-arginine transport. A limited L-arginine availability could be the explanation for the observed increased incidence of cardiovascular events in CRF patients with malnutrition.
King's College London (2005) J Physiol 565P, PC152
Communications: The effects of nutritional status on L-arginine-NO pathway in platelets from haemodialysis patients
Demezio da Silva, CV ; Moss, MB ; Brunini, TMC ; Santos, S ; Costa, EAO ; Perim, N ; Aibe, MS ; Mann, GE ; Ellory, JC ; Mendes Ribeiro, AC ;
1. Departamento de Farmacologia e Psicobiologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. 2. Departamento de Nefrologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. 3. Departamento de Farmacologia, UNIRIO, Rio de Janeiro, Brazil. 4. Centre for Cardiovascular Biology and Medicine, King's College London, London, United Kingdom. 5. Physiology Department, University of Oxford, Oxford, United Kingdom.
View other abstracts by:
Where applicable, experiments conform with Society ethical requirements.